MARATTO

preprint · SSRN Electronic Journal

Short-Cycle Therapy (Weekends-Off) on Dolutegravir-Based Antiretroviral Therapy in Adolescents Living with HIV (BREATHER Plus): A Randomised, Open-Label, 96-Week Non-Inferiority Trial

2025Open accessMoi University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.2139/ssrn.5409101

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.